Latest

Dec 18, 2020, 17:21 ET PharmaCielo Announces Appointment of Caroline Lenardon for Expansion of Retail Investor Relations Capacity

TORONTO, Dec. 18, 2020 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil,...


Dec 11, 2020, 08:30 ET PharmaCielo Enters Strategic Alliance to Provide Pre-Tested and Insured Product to Customers in the U.S. Market

Alliance with AssuredTrans Inc. will enable PharmaCielo to provide up-front independent laboratory analysis and insurance of its recently expanded product portfolio to potential customers in the...


Dec 07, 2020, 08:30 ET PharmaCielo Receives Approximately CDN$3.0 Million in Non-Dilutive Funding from Colombian State-Owned Banco Agrario

Loan of COP$8.5 billion (approximately CDN$3.0 million1) has an 84-month term, 10.14% coupon and revolving component with no equity dilution This loan together with the proceeds of the recent...


Dec 03, 2020, 08:30 ET PharmaCielo Welcomes Landmark United Nations Decision to Remove Cannabis from Narcotic Drugs List

TORONTO, Dec. 3, 2020 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF) the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade...


Dec 02, 2020, 06:00 ET PharmaCielo Announces Grant of Stock Options

TORONTO and RIONEGRO, Colombia, Dec. 2, 2020 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO), the Canadian parent of Colombia's premier cultivator and producer of...


Nov 30, 2020, 07:30 ET PharmaCielo Announces Financial Results for the Third Quarter Ended September 30, 2020

Effective December 1, Henning von Koss has been named CEO of PharmaCielo, replacing departing CEO David Attard. Successful achievement of Q3 operational milestones: Processing and Extraction Centre...


Nov 30, 2020, 07:30 ET PharmaCielo Ltd. Announces New Leadership

David Attard and Board of Directors reach mutual agreement under which David will step down as Chief Executive Officer and PharmaCielo board member, effective December 1st, 2020. Henning von Koss,...


Nov 25, 2020, 08:30 ET PharmaCielo Achieves Good Agricultural and Collection Practices (GACP) Designation

Designation brings PharmaCielo a step closer to EU-GMP compliance; supports continued expansion of medicinal-grade extract exports GACP certification is based on WHO guidelines for quality assurance...


Nov 23, 2020, 08:30 ET PharmaCielo Announces Closing of $10M Private Placement

TORONTO, Nov. 23, 2020 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF) is pleased to announce the closing of its previously announced private placement of units...


Nov 19, 2020, 08:30 ET PharmaCielo Mexico Salutes Mexican Senate for Advancing Cannabis Legalization

TORONTO and MEXICO CITY, Nov. 19, 2020 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF) and MINO Labs S.A. de C.V. ("MINO Labs"), the founders of PharmaCielo S.A. ...


Nov 18, 2020, 08:30 ET PharmaCielo Enters U.K. Market with 500kg Initial Shipment to Established Manufacturer and Distributor - Reaches 2021 Agreement

Including Initial Shipment, PharmaCielo will deliver total 1,000 kg of product to Customer – with revenue and cash flow reflected in 2020; interim 2021 sales agreement reached for continued Q1 volume ...


Nov 16, 2020, 07:30 ET PharmaCielo to Hold Conference Call to Review Third Quarter 2020 Financial Results

TORONTO and RIONEGRO, Colombia, Nov. 12, 2020 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer...


Nov 13, 2020, 08:00 ET PharmaCielo to Participate in 2020 Cowen Boston Cannabis Conference

TORONTO, Nov. 13, 2020 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade...


Nov 05, 2020, 07:30 ET PharmaCielo Begins Harvest of High-THC Cultivars for Extract Export

First harvest cycle of high-THC cultivars expected to yield more than 10 tonnes of dry flower for extract processing Extracts from six psychoactive cultivars part of Company's expanded product...


Nov 03, 2020, 07:30 ET PharmaCielo Announces Upsizing of Private Placement Offering

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, Nov. 3, 2020 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO)...


Nov 02, 2020, 17:27 ET PharmaCielo Ltd. Expands Board Depth and Expertise with Appointment of Marc Lustig as Lead Director and Strengthens Capital Position with Private Placement Offering

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, Nov. 2, 2020 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO)...


Oct 23, 2020, 08:00 ET PharmaCielo to Participate in Cantor Fitzgerald Latin America Cannabis Seminar

TORONTO, Oct. 23, 2020 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade...


Sep 22, 2020, 08:20 ET PharmaCielo Declared 'Project of National Strategic Interest' by Government of Colombia

TORONTO and RIONEGRO, Colombia, Sept. 22, 2020 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer ...


Sep 21, 2020, 08:00 ET PharmaCielo Expands Portfolio of Cannabis Extracts to Meet Global B2B Medical-Grade Market Demand

New offerings allow PharmaCielo to respond to market demand with expanded product range Extracts derived from proprietary cultivars and produced internally at 30,000+ sq. ft. processing and...


Aug 31, 2020, 07:30 ET PharmaCielo Announces Financial Results for the Second Quarter Ended June 30, 2020 and Provides Operational Update

Revenue continues to accelerate. The Company generated $1.2 million in revenue during Q2-2020, reaching $1.7 Million YTD 2020 compared to $786,901 in its full 2019 fiscal year. Recent increase in...


Aug 18, 2020, 07:30 ET PharmaCielo to Hold Conference Call to Review Second Quarter 2020 Financial Results

TORONTO and RIONEGRO, Colombia, Aug. 18, 2020 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer...


Aug 13, 2020, 07:30 ET PharmaCielo Increases Cannabis Cultivation Through External Contractor to Meet Market Demand for Medicinal Extracts

Additional area under active cultivation expands PharmaCielo's immediate footprint by 32 percent to 1.6 million square feet with further expansion pending grower license approval Company activates...


Aug 07, 2020, 12:29 ET PharmaCielo Announces Results of AGM

TORONTO, Aug. 7, 2020 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade...


Jul 08, 2020, 08:30 ET PharmaCielo Receives Colombian Government Authorization for 10 Tonnes of High-THC Cultivation and Extract Production for Export

Enables PharmaCielo to produce and deliver psychoactive extracts as part of the three-year extracts agreement the Company announced in January of this year, intended for the German market Enhances...


Jul 03, 2020, 10:57 ET PharmaCielo Ltd. Closes $4.6 Million Bought Deal Offering

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./ TORONTO, July 3, 2020 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO)...